XENE
USDXenon Pharmaceuticals Inc. Common Shares
Precio en Tiempo Real
Gráfico de Precios
Métricas Clave
Métricas de Mercado
Apertura
$39.740
Máximo
$40.450
Mínimo
$37.625
Volumen
0.18M
Fundamentos de la Empresa
Capitalización de Mercado
3.0B
Industria
Biotecnología
País
Canada
Estadísticas de Negociación
Volumen Promedio
0.79M
Bolsa
NGM
Moneda
USD
Rango de 52 Semanas
Noticias Relacionadas
RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $58
RBC Capital analyst Brian Abrahams maintains Xenon Pharmaceuticals with a Outperform and raises the price target from $55 to $58.
Wells Fargo Maintains Overweight on Xenon Pharmaceuticals, Lowers Price Target to $44
Wells Fargo analyst Benjamin Burnett maintains Xenon Pharmaceuticals with a Overweight and lowers the price target from $48 to $44.
Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $55 Price Target
Needham analyst Serge Belanger reiterates Xenon Pharmaceuticals with a Buy and maintains $55 price target.
Xenon to Report Q3 2025 Financial Results on November 3, 2025
VANCOUVER, British Columbia and BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and
Acciones Relacionadas
MREO
Mereo BioPharma Group plc American Depositary Shares
OFIX
Orthofix Medical Inc. (DE)
USPH
U.S. Physical Therapy Inc.
GFR
Greenfire Resources Ltd. Common Shares
HBM
Hudbay Minerals Inc. Ordinary Shares (Canada)
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.